Back to Authors

Bienfait, Tessa M.

A5136200788 | I2801952686

Mayo Clinic

Erasmus MC

Citations 2

Early Recognition of Treatment‐Responsive Rapidly Progressive Dementia: The Modified STAM3 m P Score

Annals of Clinical and Translational Neurology | May 28, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1002/acn3.70434 | PMID 42203753

ABSTRACT Early identification of patients with treatment‐responsive rapidly progressive dementia (RPD) is important as early treatment improves outcomes. The STAM 3 P score identifies treatment‐responsive RPD using “high risk” presenting features. We optimized performance by adding a time component (i.e., dementia within 3 months) and validated the modified “STAM3 m P score” in two independent cohorts ( n = 302). A STAM3 m P score ≥ 1 identified 96% of patients with treatment‐responsive RPD; ≥ 3 features were highly specific (98%). These data suggest that ≥ 1 STAM3 m P features effectively identifies treatment‐responsive RPD and may be used to prioritize investigations, whereas ≥ 3 STAM3 m P features are highly specific and may inform early treatment decisions.
Autoimmune Encephalitis as Treatment-Responsive Cause of Rapidly Progressive Dementia

Neurology | May 15, 2026 | Volume: 106 | Issue: 11 | Pages: No page available

10.1212/wnl.0000000000214933 | PMID 42139653